drugset / Trial / NCT02667444

P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne

NCT02667444 ↗

Phase 3 Completed 1330 enrolled Novan, Inc. Chiltern International Inc. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a 12 week, multi-center, double-blinded, randomized, vehicle-controlled, parallel group, study to be conducted in approximately 1300 subjects with acne vulgaris in the US.

Timeline

Start
2016-02-19
Primary completion
2016-12
Completion
2016-12-09

Drugs

EvaluationDrugModalityDoseRoute
Subject BERDAZIMER SODIUM Small molecule 4 % Topical

Indications